RADIOGARDASE (PRUSSIAN BLUE) Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Radiogardase (prussian Blue), and what generic alternatives are available?
Radiogardase (prussian Blue) is a drug marketed by Heyl Chemisch and is included in one NDA.
The generic ingredient in RADIOGARDASE (PRUSSIAN BLUE) is ferric hexacyanoferrate(ii). There are twenty drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ferric hexacyanoferrate(ii) profile page.
Summary for RADIOGARDASE (PRUSSIAN BLUE)
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
DailyMed Link: | RADIOGARDASE (PRUSSIAN BLUE) at DailyMed |
Pharmacology for RADIOGARDASE (PRUSSIAN BLUE)
Drug Class | Decorporation Agent |
Mechanism of Action | Chelating Activity Ion Exchange Activity |
US Patents and Regulatory Information for RADIOGARDASE (PRUSSIAN BLUE)
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Heyl Chemisch | RADIOGARDASE (PRUSSIAN BLUE) | ferric hexacyanoferrate(ii) | CAPSULE;ORAL | 021626-001 | Oct 2, 2003 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |